Back

Long-term beta-blocker therapy after revascularised acute coronary syndrome (ACS) with preserved ejection fraction: a multi-centre retrospective cohort study

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes treatment optimisation Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jih Tze Tan

Dalin Tzu Chi General Hospital, Chiayi (Taiwan)

4 More presentations in this session

Presentation thumbnail
Upfront combination lipid-lowering therapy in acute coronary syndrome: a bayesian network meta-analysis of low-density lipoprotein cholesterol reduction and major adverse cardiovascular events
Mr P. Sanjayanthan Keerthi (Chennai, IN)
Abstract
Presentation thumbnail
Antithrombotic strategies in conservatively managed patients with spontaneous coronary artery dissection
Doctor D. Wussler (Basel, CH)
Abstract
Presentation thumbnail
Early intensive combination lipid-lowering therapy in statin-naïve acute coronary syndrome: real-world attainment of lipid targets and analysis of therapeutic gaps
Professor G. Tan (Shatin, HK)
Abstract
Presentation thumbnail
Benefit of upfront combination lipid-lowering therapy in statin-naïve acute coronary syndrome patients with intermediate admission LDL-C and Lp(a)-driven predicted monotherapy failure
Doctor F. Buendia Santiago (Cartagena, ES)
Abstract

Access the full session

Session thumbnail
Acute coronary syndromes treatment optimisation

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction
26 August 2023
thumbnail
Congress Presentation
Validation of a novel framework defining the acceptable standard of care for heart failure with reduced ejection fraction
30 June 2021
thumbnail
Congress Presentation
Adherence to cardiac rehabilitation after acute coronary syndrome and its impact on patient outcome
1 September 2020
thumbnail
Congress Presentation
Safety of beta-blocker discontinuation in patients after acute coronary syndromes and preserved left ventricular ejection fraction: long-term clinical outcomes from the SPUM-ACS cohort
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources